Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Alternative Treatment Options for Migraine Relief

First-Line Alternative Treatments

  • The American College of Physicians recommends considering CGRP antagonists (gepants), dihydroergotamine (DHE), or the ditan lasmiditan as first-line alternatives for acute migraine treatment in patients who cannot take NSAIDs or triptans 1
  • CGRP antagonists, such as rimegepant, ubrogepant, or zavegepant, are considered for moderate to severe acute episodic migraine headaches 1
  • Dihydroergotamine (DHE) is available in intranasal formulation with good evidence for efficacy and safety 2
  • Lasmiditan (Ditan) is considered for moderate to severe acute episodic migraine headache when other options are contraindicated or ineffective 1, 3

Second-Line Alternative Treatments

  • Acetaminophen-based combinations, such as acetaminophen and caffeine, can be effective for mild to moderate migraines 4, 5
  • Isometheptene combinations, such as Midrin, have shown effectiveness for milder migraine headaches 4, 5
  • Antiemetics, such as metoclopramide or prochlorperazine, can effectively relieve headache pain in addition to treating nausea 4, 5

Treatment Algorithm Based on Migraine Severity

  • For mild to moderate migraines, consider acetaminophen + caffeine combination, isometheptene combinations, or CGRP antagonists if above options fail 1, 3, 4, 5
  • For moderate to severe migraines, consider CGRP antagonists (rimegepant, ubrogepant, zavegepant), dihydroergotamine (intranasal formulation preferred), or lasmiditan if other options fail 1, 2, 3

Special Considerations

  • Avoid opioids and butalbital-containing medications for routine migraine treatment as they can lead to dependency, rebound headaches, and eventual loss of efficacy 1, 3
  • Systemic steroid therapy may be the treatment of choice for status migrainosus (severe, continuous migraine lasting up to one week) 7
  • Monitor for medication overuse headache, which can occur with frequent use of acute medications (≥15 days per month with most medications; ≥10 days per month with triptans) 1

Treatment Failure Considerations

  • If first-line alternatives fail, consider combination therapy or rescue medications such as antiemetics or corticosteroids 7
  • For refractory cases, evaluate for preventive therapy to reduce frequency and severity of attacks 1, 3
  • Non-pharmacological approaches, including lifestyle modifications, should be emphasized alongside pharmacological treatment 1